The Ma’anshan site approval covers pastilles, oral liquids, and powders
This certification validates the plant’s robust capabilities in manufacturing a wide range of sterile dosage forms
This was a full GMP inspection of the entire facility with specific focus on Ondansetron Oral Film drug product
The iStent platform uses tiny surgical implants to lower eye pressure by restoring the eye’s natural fluid drainage system in patients with glaucoma
Facility also named 2025 ISPE Facility of the Year Winner for Social Impact - Unmet Medical Needs
This recertification of Company's OECD GLP is testimony to company's unwavering commitment to maintain international quality standards at the facility
The MDR certification reafirms that these products meet the highest safety, quality, and regulatory standards
The certification marks a new chapter in Windlas Biotech’s growth trajectory,
Subscribe To Our Newsletter & Stay Updated